You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to ...

Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

In Australia, Mounjaro, Wegovy and Saxenda (liraglutide) are approved for weight loss. People on these medications commonly ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

With off-label use, a drug is prescribed for a use other than that approved by the Food and Drug Administration (FDA). The FDA has approved Wegovy and Mounjaro for the following uses in adults ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...